Clinical microorganisms isolated during a 5-year study in our hospital that could not be identified by conventional criteria were studied by 16S rRNA gene sequence analysis. Each isolate yielded a >1,400-bp sequence containing <5 ambiguities which was compared with the GenBank 16S rRNA gene library; 1,404 such isolates were tested, and 120 were considered unique (27 isolates) or rare (<10 cases reported in the literature) human pathogens. Eleven new species, "Actinobaculum massiliae," "Candidatus Actinobaculum timonae," Paenibacillus sanguinis, "Candidatus Bacteroides massiliae," Chryseobacterium massiliae, "Candidatus Chryseobacterium timonae," Paenibacillus massiliensis, "Candidatus Peptostreptococcus massiliae," "Candidatus Prevotella massiliensis," Rhodobacter massiliensis, and "Candidatus Veillonella atypica" were identified. Sixteen species were obtained from humans for the first time. Our results show the important role that 16S rRNA gene sequence-based bacterial identification currently plays in recognizing unusual and emerging bacterial diseases.16S rRNA gene sequencing (39) was first proposed to identify uncultured microorganisms (17,25,38), but the idea that it could be used for bacterial identification of cultured bacteria in clinical laboratories has become increasingly realistic (7,8,34,36), and the technique is now commercially available (6,34,35).Identification of organisms by 16S rRNA gene sequencing has been described in case reports and in reports focusing on a particular bacterial phylum or genus, such as Mycobacterium (6, 36), Actinomyces (15, 28), aerobic gram-negative bacilli (8, 34), coryneform bacteria (35), and aerobic gram-positive rods (3), and we previously reported a series including both environmental and clinical isolates (7).Although 16S rRNA gene sequence analysis has become a common method for the accurate identification of bacterial isolates (24), and its definition of bacterial species has been precise (30), the impact of systematic sequencing of unidentified bacteria in a clinical laboratory setting has seldom been evaluated (3). 16S rRNA gene sequence-based descriptions of new taxa are still a matter of debate (19). We therefore evaluated our experience in systematic sequencing of unidentifiable bacterial isolates for the purpose of describing new taxa and new clinical entities.
MATERIALS AND METHODSBacterial isolates. Our laboratory serves a 3,500-bed university-affiliated tertiary-care institution and routinely processes human samples for culture-based diagnosis of bacterial infectious diseases, including those due to anaerobes, aerobes, mycobacteria, and spirochetes. Infections by intracellular pathogens are diagnosed and researched in another laboratory and were not included in this study.Our laboratory also acts as a regional center of expertise in microbial identification and receives unidentified bacterial isolates from all over the Marseilles metropolitan area. Conventional laboratory techniques used for phenotyping were carried out on all isolates according to stan...